Introduction
Abnormalities of chromosomal structure and number are characteristic features of cancer and the development of such abnormalities usually involves two major pathways: cell division and DNA damage. Defects in cell mitosis include failure of chromosomal condensation, segregation and partition. The centrosome is the principal eukaryotic microtubule-organizing center, and it initiates assembly of the spindle and it is involved in segregating the duplicated chromosomes. Centrosomal aberration (amplification) leads to chromosome missegregation and the development of numerical chromosome abnormalities secondary to deformation of mitotic spindles (multipolar, monopolar or unbalanced) (Fukasawa, 2005; Saunders, 2005) . A large body of evidence regarding centrosome amplification in human cancers has been compiled, and amplification of centrosomes is believed to be an early feature in tumor initiation/ progression (Pihan and Doxsey, 1999; Lingle and Salisbury, 2000; Brinkley, 2001) . The development of centrosome abnormalities in tumorigenesis may result from various situations, including exposure to genotoxic agents, cell stress, oncogenic virus, mutation of oncogenes and tumor suppressor genes such as p53, BRCA1 or ATM (Morris et al., 2000; Fukasawa, 2005; McPherson et al., 2006) . At the same time, the signaling machinery involved in DNA damage response has been clearly determined to play a critical role in the process of centrosome amplification (Fletcher and Muschel, 2006; Loffler et al., 2006) .
Telomere loss occurring in DNA duplication is another path leading to DNA damage, and it has also received significant attention in the recent past. The telomere, a DNA-protein complex that protects the ends of chromosomes, is closely associated with chromosome integrity and stability. The maintenance of telomeres constitutes an integral part of the DNA damage response. When the telomere becomes critically short secondary to loss of its repeats in accelerated proliferation of cells or disruption of the capping proteins, the free ends of telomeres activate ATM, which triggers a signal cascade through successive phosphorylation of factors that are critical to the DNA damage response, such as ATM, p53, BRCA1 or other factors, and forces cells into cell cycle arrest, senescence or apoptosis (Churikov et al., 2006; Slijepcevic, 2006) . Failure in this response due to mutation of the signaling genes may otherwise allow cells to escape to mitosis, leading to chromosome abnormalities (Gisselsson, 2001 (Gisselsson, , 2003 . Therefore, as might be expected, telomeric erosion and mutations in these factors, which are critical to the damage response, are commonly detected in many human cancers (Hackett and Greider, 2002; Masutomi et al., 2003) .
There is apparently a mechanism in common, involving a set of genes such as ATM, p53 or BRCA1, which participates both in the regulation of telomere maintenance and in centrosome homeostasis. In fact, both telomeric erosion and centrosome abnormalities have been detected coincidently in most human cancers (Saunders, 2005) . Furthermore, some viral oncoproteins such as E6 of HPV, tax of HTLV-1 or X of HBV can experimentally induce not only centrosome amplification but also telomere dysfunction, and can even activate cellular telomerase (Lavia et al., 2003; PlugDeMaggio et al., 2004; Pumfery et al., 2006; Bellon and Nicot, 2008; Hara et al., 2008) . In addition, depletion of POT1, a factor critical in telomere protection, is able to induce centrosome amplification (Churikov et al., 2006) . Tankyrase or PARP (human poly (ADP-ribose) polymerase), a TRF1 interacting protein, has been found to undergo redistribution in mitotic centrosomes (Smith and de Lange, 1999; Wang et al., 2007) . More directly, Bqt1 and Bqt2 in yeast also form a bridge between Rap1 and Sad1, essential for connecting telomeres to the spindle pole body in meiosis (Chikashige et al., 2006) . Such findings therefore raise the possibility that some of the factors involved in the maintenance of telomeres may also be functionally involved in the regulation of the centrosome.
TEIF (telomerase transcriptional elements-interacting factor), which has been primarily identified as a transactivator of the hTERT (human telomerase reverse transcriptase subunit) gene, can stimulate telomerase activity (Tang et al., 2004) . Overexpression of TEIF has been detected in most human carcinomas, consistent with the expression of hTERT, whereas its downregulation can suppress growth or tumorigenicity of cancer cells (Tang et al., 2003) . In addition, TEIF can also upregulate the expression of DNA polymerase-b, the enhanced activity of which is implicated in inducing genomic mutation based on its lower fidelity of nucleotide incorporation (Zhao et al., 2005) . Here, we further demonstrate that TEIF protein may redistribute in the centrosome and it is involved in the regulation of the status of this organelle in DNA damage, telomere dysfunction and human cancer.
Results

Dynamic distribution of TEIF in the centrosome
In our previous study of the subcellular localization of TEIF protein, we found that it showed predominantly nuclear distribution in interphase (Tang et al., 2003) . In addition, recent immunofluorescent analysis showed that TEIF was both concentrated in a single or double spot near the nucleus and diffusely scattered in the nucleus and cytoplasm in interphase. While in metaphase, the distribution of TEIF included two intense foci located symmetrically at both polarized spindle sites of the condensed chromosome (Figure 1a) . The location of these foci, which stained in both interphase and mitotic phases, raised the possibility that TEIF localizes in the centrosome. To evaluate this possibility, double staining with TEIF and g-tubulin (a centrosomal component), or a-tubulin (a spindle protein) was performed in a series of cell lines (U2-OS, Saos-2, HeLa, PC3M and Hep2 cells). Immunofluorescent assay showed that staining of TEIF foci overlapped with g-tubulin staining in both interphase and metaphases (Figures 1c and d) , but did not overlap with a´-tubulin ( Figure 1b) . These results indicate that some of TEIF proteins are distributed in centrosomes.
To further verify centrosomal distribution of TEIF and to identify subregions of TEIF involved in centrosomal targeting, fusion protein analysis using green fluorescence protein (GFP) was carried out. As no transcript of any TEIF isoform has been found (Tang et al., 2004) , a series of constructs with various segments of TEIF fused to GFP were prepared. GFP-TEIF-EX corresponds to the nearly full-length sequence of TEIF, and GFP-TEIF-DEB and GFP-TEIF-DEF comprise about 20 and 50% of its N-terminal sequences, whereas GFP-TEIF-DHX and GFP-TEIF-DFX cover about 80 and 50% of the C-terminal coding region, respectively ( Figure 2a ). Five kinds of GFP-TEIF were transiently transfected into U2-OS, Saos-2, HeLa and PC3M cells. Distribution of these GFP-TEIF constructs was monitored in conjunction with staining of g-tubulin (Figure 2b ). Exogenous proteins derived from GFP-TEIF-EX displayed diffuse distribution in the cytoplasm and nuclei as well as in condensed spots, which overlapped with g-tubulin, whereas the fusion protein expressed from the construct GFP-TEIF-DHX was concentrated predominantly in foci that colocalized with g-tubulin. Similarly, GFP-TEIF-DFX dominantly colocalized with g-tubulin together with some scattered nuclear foci. In contrast, GFP-TEIF-DEB and GFP-TEIF-DEF were diffused in the cytoplasm and nuclei and did not show centrosomal localization. These experiments confirmed that TEIF localizes in centrosomes and indicated that the domains for centrosomal targeting reside in the C terminus segment (amino acids 365-786).
Effects of TEIF expression on centrosome status
This association of TEIF with centrosomes raised the possibility that the expression level of TEIF might affect centrosome status. To test this hypothesis, centrosomes were evaluated under various alterations of TEIF expression, including overexpression, polypeptide expression (segments of TEIF) and depletion by RNA interference.
Expression of exogenous TEIF in HeLa cells (or Saos-2 and so on) led to intense TEIF staining in the cytoplasm and nuclei, with particular concentration at the centrosomes (Figure 3) , and this was accompanied by slight centrosome amplification (from o2 to 4%) and an increase in multinucleated cells (>2-fold increase). In addition, cells with transfection of TEIF-DHX (deleted N-terminal 155 amino acids) showed intense staining, enlarged centrosomes and large mononucleated cells (four or fivefold larger than the original size) (Figure 3 ). These results were consistent with those found using GFP-TEIF or GFP-TEIF-DHX.
It was of interest that overexpression of C-terminal truncated TEIF (TEIF-DEF), which resulted in diffuse distribution in the cytoplasm and nuclei but did not show accumulation in the centrosome, also caused a significant increase in multinucleated cells (Figure 3 ), as did GFP-TEIF-DEF (Figure 2b ).
The role of TEIF in the regulation of the centrosome was further analysed by the suppression of TEIF expression. The knockdown of TEIF expression in U2-OS and Saos-2 cells was achieved by RNA interference and a significant decrease in TEIF expression was verified by RT-PCR, western blotting and immunofluorescent staining. Centrosomes were evaluated in TEIF-depleted cells, and we unexpectedly found that TEIF depletion also resulted in an increasing population of cells with supernumerary centrosomes. Both TEIFdepleted U2-OS and Saos-2 showed a more than twofold increase in the number of cells harboring more than two centrosomes (Figures 4a and c) . It was also remarkable that insufficiency of TEIF in some cells led to multiple centrosomes varying in size and shape, which appeared to result from centrosomal fragmentation (arrow in the lowest panel of Figure 4a ). This centrosome amplification was further verified by quantification of g-tubulin with western blotting, which showed an increase in the average g-tubulin content in TEIFdepleted U2-OS cells (Figure 4b ), consistent with our observations in immunofluorescent staining.
In addition to multiple centrosomes, TEIF-depleted U2-OS and Saos-2 cells showed an increase in multinucleated cells and more mitotic disturbances, including cells with multipolar and monopolar spindles, and chromosome mis-segregation ( Figure 4a ). There was an approximately threefold increase in the number of multinucleated cells following depletion of TEIF in Saos-2 cells, whereas in TEIF-depleted U2-OS cells, there was an identifiable difference in multinucleated cells before and after TEIF depletion, although it was not as great as in the Saos-2 cells (Figure 4c ). In addition, most of these multinucleated cells contained an abnormal number of centrosomes. Similarly, centrosomal amplification and abnormal mitoses induced by TEIF depletion were also observed in Hep2 and HeLa cell lines (data not shown). Taken together, these results indicate that appropriate expression of TEIF is required for the maintenance of centrosome homeostasis.
Increases in centrosomal TEIF accompany centrosome amplification in DNA damage and telomere dysfunction In addition to centrosomal localization, TEIF is also found in other cellular compartments. We thus wondered what circumstances might bring about translocation of TEIF into the centrosome. Increasing evidence has demonstrated that migration of proteins to the centrosome generally occurs under cell stress, especially in DNA damage response. Our previous results showed that TEIF upregulates in the presence of genotoxic agents and stimulates the expression of DNA polymerase-b (Zhao et al., 2005) , and this prompted us to evaluate TEIF centrosome distribution in DNA damage response.
After treatment of cells with H 2 O 2 , or cisplatin or bleomycin, both staining of TEIF and g-tubulin became much more intense (double immunofluorescent staining) and centrosomes became enlarged (Figure 5a ). At the same time, cells with supernumerary centrosomes (>2 per cell) also increased markedly from o2 to B10% in the presence of genotoxic agents (Figure 5a ), suggesting that TEIF might be involved in the centrosome response to DNA damage.
As TEIF is a telomerase regulator and the status of telomere integrity is functionally associated with DNA damage response, it was reasonable to suppose that telomeric dysfunction might also affect TEIF centrosome distribution. To mimic telomere dysfunction, synthesized T-oligo was used to treat U2-OS and Saos-2 cells. Under treatment with 20 nM T-oligo, centrosomes were analysed by double immunofluorescent staining of TEIF and g-tubulin. Compared with control cells, T-oligotreated cells exhibited intense TEIF and g-tubulin staining, and the number of brighter and enlarged centrosomes increased markedly (Figure 5b) . Similarly, T-oligo-treated U2-OS and Saos-2 cells showed an increase in cells with supernumerary centrosomes (increase from o2 to B4% in both cell lines), and an increase in multinucleated cells and mitotic abnormalities (Figure 5c ).
To directly investigate the effects of telomere dysfunction on centrosomal distribution of TEIF, disruption of the endogenous telomere protein shelterin was achieved by depletion of TRF1 and POT1, which are key proteins in the protection of the telomeric ends. siRNAs targeting TRF1 and POT1 were designed and transiently transfected into U2-OS cells. Transient depletion of either POT1 or TRF1 was able to significantly induce TEIF centrosomal distribution (Figure 5b) . POT1 depletion induced a threefold (from o2 to B6%) increase in supernumerary centrosomes in U2-OS cells, whereas inhibition of TRF1 induced supernumerary centrosomes in U2-OS cells, albeit to a lesser extent (from o2 to B3%). Mitotic disturbances and multinucleated cells were also observed with depletion of POT1 and TRF1 (Figure 5d) . Similarly, telomere dysfunction-induced centrosomal amplification and abnormal mitoses were also observed in HeLa, PC3M and Hep2 cells (data not shown).
In conclusion, DNA damage and telomere dysfunction lead to increased loading of TEIF onto centrosomes and resulted in centrosome amplification.
Overexpression of TEIF correlates with centrosome amplification in human sarcomas
Telomere dysfunction and DNA damage are causative events in tumorigenesis. The response of TEIF to such events allowed exploration of the relationship between TEIF expression and centrosome amplification in human cancers. Using tissue microarray-based immunostaining of TEIF and immunofluorescent histochemistry with g-tubulin, we evaluated the correlation between TEIF expression and centrosome status in a collection of 104 sarcomas and 14 benign tumors or tumor-like lesions (representative images in Figure 6a) .
The results of centrosome staining in 118 cases of benign and malignant soft tissue tumors and its correlation with TEIF staining are summarized in Table 1 . Centrosome amplification was detected in 45 cases of 64 TEIF-positive soft tissue tumors for a total positive rate of 70%, in contrast to only in 13 of 54 (24%) cases that showed centrosome amplification in TEIF-negative cases. This difference was statistically significant (Po0.01). Most of the sarcomas were TEIF positive (61/104, 59%) and showed centrosomal abnormalities (54/104, 52%), which were significantly more frequent than in benign tumors (21 and 29%, respectively). In addition, we analysed the correlation between intensity of TEIF staining and centrosomal aberrations (Figure 6b ). Supernumerary centrosomes were detected in 24% (13/54) of TEIF-negative cases, but increased to 40% (6/15) in cases with (1 þ ) positive TEIF staining, and to 74% (25/34) in 2 þ positive cases, and was as high as 93% (14/15) in cases with 3 þ TEIF staining (Figure 6b ). This suggests that there is a Even more compelling was the frequency of supernumerary centrosomes in highly aggressive types of sarcomas, which included 89% (8/9) of primitive neuroectodermal tumor, 75% (6/8) of synovial sarcoma, 67% (6/9) of rhabdomyosarcoma and 63% (22/35) of malignant fibrous histiocytoma, and this was statistically different from the frequency of supernumerary centrosomes found in moderate grade sarcomas such as 21% (3/14) of liposarcoma and 18% (2/11) of leiomyosarcoma (Table 1 ). The group of highly aggressive sarcomas also showed strong positive TEIF staining (X2 þ ), in which numbers of cases of primitive neuroectodermal tumor and synovial sarcoma with strong TEIF-positive staining (X2 þ ) were as high as 89% (8/9) and 88% (7/8), and rhabdomyosarcoma and malignant fibrous histiocytoma were 67% (6/9) and 49% (17/35), respectively; much higher than for leiomyosarcoma (27%, 3/11) and liposarcoma (21%, 3/14) ( Table 2 ). This suggests that centrosome amplification with overexpression of TEIF may reflect the malignant potential of sarcomas.
Discussion
It is now well known that the centrosome mediates functions that range far beyond its traditionally recognized role as a microtubule organizing center, and it in fact serves as a multiplatform scaffold for a multitude of signaling networks (Doxsey, 2001a, b; Doxsey et al., 2005a, b) . Proteomic evaluation has revealed that in addition to its structural resident proteins, the centrosome is comprised of hundreds of proteins involved in cell cycle control, cytokinesis, DNA damage response, tumorigenesis and so on (Andersen et al., 2003) . Protein traffic into or out of the centrosome may thus be reasonably understood as a continuous series of events in living cells, and the composition of the centrosome thus changes dynamically with its varying status (Doxsey, 2001; Doxsey et al., 2005a, b) .
Our results demonstrated that centrosomal translocation of TEIF is mediated by its C-terminal domain. Although a specific conserved coiled-coil domain has been identified, which is responsible for directing many proteins into the centrosome, there are still other proteins that apparently make use of different sequences for this purpose (Gillingham and Munro, 2000; Matsumoto and Maller, 2004; Momotani et al., 2008) . Moreover, no similar sequences have been found in ATM, p53 or BRCA, but these proteins are all able to redistribute to the centrosome, indicating that there is diversity in signaling sequences. On the other hand, under some circumstances it appears that the traffic to The group of benign tumors or tumor-like lesions of soft tissue (n ¼ 14) consists of leiomyomas, neurilemomas, lipomas and fibrous histiocytomas. A significant increase (>15%) in the number of cells with supernumerary centrosomes (>2 signals per cell) was defined as positive (SNCe+). Any smaller percentage was defined as negative (SNCeÀ). 8  1  0  5  2  88  Rhabdomyosarcoma  9  2  1  4  2  67  MFH  35  15  3  13  4  49  Leiomyosarcoma  11  5  3  3  0  27  MPNST  18  11  3  3  1  22  Liposarcoma  14  8  3  2  1  21 Abbreviations: MFH, malignant fibrous histiocytoma; MPNST, malignant periphery nerve sheath tumor; PNET, primitive neuroectodermal tumor; TEIF, telomerase transcriptional elements-interacting factor. a Staining was graded as follows: À, almost complete no staining; 1+, light staining; 2+, strong staining; 3+, very strong staining. b The strong positive rate is the percentage of strong positive (X2+) cases found among the total cases in each group.
the centrosome simply requires specific mediators. For instance, the classic centrosome protein TACC2 and some regulators such as Erk2, p53 and BRCA1 distribute into centrosomes after phosphorylation (Dou et al., 2004; Lou et al., 2004; McPherson et al., 2006) . However, in contrast to the putative N-terminal STYKc (Ser/Thr/Tyr) kinase-like domain, the C terminus of TEIF has no conserved functional domains shared with proteins in either the centrosome or other compartments. This means that traffic of TEIF to the centrosome likely relies on its own C-terminal sequence, which may interact with other factors or be modified by phosphorylation for increasing its centrosomal concentration in response to DNA damage and telomere dysfunction.
In this study, we observed that DNA damage also induced TEIF traffic into centrosomes, and this was a rapid process that occurred within minutes after DNA damage (for example, with UV irradiation) had taken place (data not shown). These results support the recent view that the centrosome is part of the network that integrates cell cycle arrest and repair signals in response to DNA damage (Ewart-Toland et al., 2003; Doxsey et al., 2005a, b; Loffler et al., 2006) . As a matter of even greater interest, we found that telomere dysfunction also increased TEIF translocation into the centrosome. This may be due to the effects of DNA damage signaling, as there is increasing evidence that most of the key proteins for the regulation of the DNA damage response are involved in telomere maintenance, including ATM, p53 and BRCA1 as previously mentioned (Churikov et al. 2006; Slijepcevic, 2006) .
We also observed that increased centrosomal translocation of TEIF led to centrosome amplification not only in DNA damage as described above but also in telomere dysfunction. The level of centrosome amplification in telomere dysfunction was somewhat lower than that which resulted from treatment with genotoxic agents, but this may have been due to the use of transient transfection of T-oligo or siRNA for POT1, TRF1 or hTERT, wherein not all of the cultured cells were completely transfected. The concurrence of telomere dysfunction and centrosome amplification plays an important role in the generation of chromosomal abnormalities that are characteristically found in neoplasia, but the mechanistic link of these two distinct cellular events is still unclear. Recently, Gisselsson proposes a hypothesis that focused on this question after analysis of a series of genetic alterations in various kinds of human cancers (Gisselsson et al., 2002 (Gisselsson et al., , 2004 Gisselsson, 2005) . According to his concept, telomeric erosion can initially induce chromosomal bridging secondary to telomeric fusion in anaphase with resultant failure in cytokinesis, giving rise to cells with supernumerary centrosomes, which consequently leads to numerical chromosomal aberrations by causing multipolar divisions. Our experimental findings also demonstrated a similar functional linkage, but at the same time suggested that telomere dysfunction most likely induced centrosome amplification not only through defective cytokinesis but also by some other pathway as well, as experimentally induced telomere dysfunction usually resulted in the appearance of enlarged centrosomes as well as an increase in centrosome number. This was somewhat similar to the centrosome changes induced by genotoxic agents. As noted above, in view of the fact that telomere dysfunction is able to trigger a DNA damage response, it is conceivable that telomeric erosion may affect the status of the centrosome and even affect its amplification under the influence of DNA damage signaling.
As illustrated by our analysis of a group of sarcomas, overexpression of TEIF was frequently found in association with centrosome amplification, and correlated with the sarcoma grade or malignant potential. However, we also unexpectedly observed that experimentally induced TEIF depletion induced centrosome amplification and aneuploidy to an even greater extent than overexpression of TEIF, and at the same time overexpression of truncated TEIF resulted in an increase in multinucleated cells, even though truncated TEIF lost its centrosome localization in the course of this process. How may this seeming contradiction between findings in vivo (sarcoma analysis) and in the in vitro model be explained? We noted some marked differences in cells with modulated overexpression of TEIF or its depletion or expression of its truncated form. In comparison with intact TEIF overexpressing cells, TEIF-depleted cells demonstrated a delay in S phase and TEIF-truncated cells usually showed a slowdown in growth (data not shown). This indicates that the expression status of TEIF led cells to different biologic outcomes, despite the fact that resultant cells contained functionally or morphologically abnormal centrosomes. Moreover, no transcript isoforms or genomic mutations of TEIF have been detected thus far (Tang et al., 2004) , and TEIF is located in a region of the chromosome that is frequently altered in cancer cells (Wong, 1999; van Asseldonk et al., 2000; Zaharieva et al., 2003; Brown et al., 2006) . We therefore suggest this is because in normal conditions appropriate expression of TEIF may be necessary to ensure the homeostasis of centrosomes, whereas its overexpression is a dominant event in spontaneous tumorigenesis. Similar mechanics of operation have in fact been identified in other centrosomal factors such as TACC, cep135, Nek2 or Aurora A kinase (Ohta et al., 2002; Stenoien et al., 2003; Dou et al., 2004; Lou et al., 2004; Peset and Vernos, 2008) .
Our investigation demonstrated that the centrosomal localization of TEIF confers a regulatory effect on the status of the centrosome in DNA damage and telomere dysfunction, and overexpression of TEIF is closely correlated with centrosome amplification and malignant potential of soft tissue sarcomas. All these results are important not only for furthering the understanding of the biological function of TEIF but may also serve to help work out the mechanism through which there is concurrence of telomere dysfunction and centrosome amplification in human cancers.
Materials and methods
Cell culture and treatment HeLa, Hep2, PC3M, U2-OS and Saos-2 cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. For cell treatment, varying concentrations of H 2 O 2 (Beijing Chemicals Inc., Beijing, China), cisplatin (Sigma, St Louis, MO, USA), or bleomycin (Sigma) were added to the medium for the indicated times.
Three synthetic oligonucleotides (Genepharma Co., Ltd, Shanghai, China) were synthesized and added to culture cells in 40 nM for 48 h. One was homologous to the telomere overhang (T-oligo, pGTTAGGGTTAG), one complementary to this sequence (pCTAACCCTAAC), and one was unrelated (pGATCGATCGAT).
Immunofluorescent microscopy Cells grown on cover slips overnight were fixed with ice-cold acetone for 10 min and blocked with horse serum for 30 min. The samples were incubated with rabbit polyclonal anti-TEIF (1:500), monoclonal anti-g-tubulin (1:2000, T6557; Sigma) or anti-atubulin (1:500; Sigma) for 1 h at room temperature, washed and further treated with fluorescein isothiocyanate or tetramethyl rhodamine isothiocyanate-conjugated secondary antibodies (Sigma) for 1 h. Nuclei were counterstained with 0.25 mg/ml 4,6-diamidino-2-phenylindole. Fluorescent microscopy was performed with an Olympus microscope (Model CX51; Olympus, Tokyo, Japan) equipped with a cold-CCD digital camera (Motic, 2000,Images advanced 3.2) and appropriate filter sets. Images were processed by Photoshop version 6.0.
To determine the number of centrosomal abnormalities in experimental cells, g-tubulin signals in 1000 cells were examined for each sample. The observation of more than two dots of g-tubulin signals per cell was considered as centrosome amplification (Fukasawa, 2005) .
Construction of plasmids and transfection
The sequences encoding TEIF-EX (full length), TEIF-DHX and TEIF-DFX, TEIF-DEB and TEIF-DEF ( Figure 2a) were fused into pEGFP-C3 vectors (BD Biosciences Clontech, Mountain View, CA, USA) or the pcDNA3.1/His vector (Invitrogen, Carlsbad, CA, USA) for generating in-frame fusion proteins. Transient transfection was carried out with Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. Stable transfectants were generated and selected in G418 (700 mg/ml) for 2 weeks.
RNAi transfection
Interfering small RNA sequences specific to TEIF (5 0 -TCCC TGTGGTGGTCAAGAT-3 0 ), TRF1 (5 0 -CGACGAGGAGC AGUUCGAATT-3 0 ), POT1 (5 0 -GUACUAGAAGCCUAUC UCATT-3 0 ), hTERT (5 0 -CACGGUGACCGACGCACUGT T-3 0 ) and control RNAi (5 0 -UUCUCC GAACGUGUCACG UTT-3 0 ) were synthesized (Genepharma). An expression vector of small hairpin RNA (shRNA: 5 0 -GATCCCCTCCCT GTGGTGGTCAAGATTTCAAGAGAATCTTGACCACCA CAGGGATTTTTGGAAA-3 0 ) targeting TEIF gene was constructed in Pgensil vector (Gensil Company, Wuhan, China) . The siRNAs were delivered into cells using Lipofectamine 2000. Cells on cover slips were fixed 48 h after transfection.
